Confluent reticulated papillomatosis - 匯合性網狀乳頭狀瘤病
References
Confluent and reticulated papillomatosis (CRP) ，也稱為 Gougerot-Carteaud 綜合徵，由皮膚細胞異常生長引起。它表現為無痛的黑斑，可以合併成更大的斑塊，通常出現在青少年和年輕人的上胸部和頸部。最初的治療選擇是米諾環素。
Confluent and reticulated papillomatosis (CRP), also known as Gougerot-Carteaud syndrome, is caused by disordered keratinization. It presents with asymptomatic hyperpigmented papules that can coalesce into plaques and are typically located on the upper trunk and neck of teens and young adults. First-line treatment is oral 'minocycline'.
Confluent and reticulated papillomatosis (CRP), also known as Gougerot-Carteaud syndrome, is caused by disordered keratinization. It presents with asymptomatic hyperpigmented papules that can coalesce into plaques and are typically located on the upper trunk and neck of teens and young adults. First-line treatment is oral 'minocycline'.
CRP 通常在頸部、腋窩、上胸部和上背部皮膚上表現為黑斑和斑塊，但沒有任何症狀。有時，它可以向上擴散到前額，向下擴散到恥骨區域。像 minocycline 這樣的抗生素已經成為首選的治療選擇。
CRP typically presents as asymptomatic hyperpigmented papules and plaques with peripheral reticulation over the nape, axillae, upper chest, and upper back, occasionally with extension superior to the forehead and inferior to the pubic region. Antibiotics, such as 'minocycline', at anti-inflammatory doses have emerged as a preferred therapeutic option.
CRP typically presents as asymptomatic hyperpigmented papules and plaques with peripheral reticulation over the nape, axillae, upper chest, and upper back, occasionally with extension superior to the forehead and inferior to the pubic region. Antibiotics, such as 'minocycline', at anti-inflammatory doses have emerged as a preferred therapeutic option.
○ 治療
#Minocycline